This article explores the difficulties faced in attempting to treat HIV, an innovative prevention strategy and the ...

while tropic switching from R5- to X4-specific HIV-1 typically occurs in the later stages of infection as mutations in the virus allow it to shift its coreceptor usage. This switch is associated with ...

An immune response that likely evolved to help fight infections appears to be the mechanism that drives human ...

Immuno Cure is a clinical stage biotechnology group based in the Hong Kong Science Park, focusing on research and development ...

A Hong Kong biotech company said its therapeutic HIV vaccine showed “promising” results in a recent clinical trial, taking it ...

Unlike progressors, people who experience the expected progression of HIV to AIDS, VNPs exhibit relatively stable CD4 + T cell counts over extended periods without antiretroviral therapy, even when ...

Highly effective treatments for HIV have existed since the mid-1990s. But while these treatments keep people healthy, we do not yet have a safe and scalable way to completely rid the body of the virus ...

The prevalence of liver steatosis was higher in people living with HIV compared with liver fibrosis, although both liver ...

Using this model, the researchers proved that the virus can infect the cells directly and that the cells can't protect themselves against it through an immune response ... such as organ transplant ...

HONG KONG SAR - Media OutReach Newswire – 12 November 2024 - Immuno Cure BioTech (" Immuno Cure "), a clinical-stage ...

Women living with HIV can reduce their risk of cervical cancer using a human papillomavirus (HPV) vaccine that is both ...